Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 280937
                    [Title] => Combination drug delays onset of kidney disease
                    [Summary] => The antihypertensive pill containing an angiotensin-converting enzyme inhibitor and a non-dihydropryridine calcium channel blocker has been shown to reduce the incidence of microalbuminuria when compared with standard treatment, according to a study published recently in the New England Journal of Medicine. 


Microalbuminuria, or small amounts of protein in the urine, is an early indicator of kidney disease and has been associated with an increased risk of cardiovascular problems.  


                    [DatePublished] => 2005-06-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

MICROALBUMINURIA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 280937
                    [Title] => Combination drug delays onset of kidney disease
                    [Summary] => The antihypertensive pill containing an angiotensin-converting enzyme inhibitor and a non-dihydropryridine calcium channel blocker has been shown to reduce the incidence of microalbuminuria when compared with standard treatment, according to a study published recently in the New England Journal of Medicine. 


Microalbuminuria, or small amounts of protein in the urine, is an early indicator of kidney disease and has been associated with an increased risk of cardiovascular problems.  


                    [DatePublished] => 2005-06-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Combination drug delays onset of kidney disease

June 9, 2005 - 12:00am

The antihypertensive pill containing an angiotensin-converting enzyme inhibitor and a non-dihydropryridine calcium channel blocker has been shown to reduce the incidence of microalbuminuria when compared with standard...

Science and Environment